Avantor, Inc. Increase (Decrease) in Interest Payable, Net
Avantor, Inc. (AVTR) reported Increase (Decrease) in Interest Payable, Net of -$15.70 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2026-04-29
- Avantor, Inc. increase (decrease) in interest payable, net for the quarter ending 2026-03-31 was -$15.70M.
- Avantor, Inc. increase (decrease) in interest payable, net for the quarter ending 2025-12-31 was $12.10M, a 18.79% decline year-over-year.
- Avantor, Inc. increase (decrease) in interest payable, net for the quarter ending 2025-09-30 was -$14.80M.
- Avantor, Inc. increase (decrease) in interest payable, net for the quarter ending 2025-06-30 was $10.70M, a 16.30% increase year-over-year.
- Avantor, Inc. increase (decrease) in interest payable, net for fiscal 2025 was -$1.30M.
- Avantor, Inc. increase (decrease) in interest payable, net for fiscal 2024 was -$1.60M, a 633.33% decline from fiscal 2023.
- Avantor, Inc. increase (decrease) in interest payable, net for fiscal 2023 was $300.00K, a 200.00% increase from fiscal 2022.
- Avantor, Inc. increase (decrease) in interest payable, net for fiscal 2022 was $100.00K, a 98.11% decline from fiscal 2021.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$15.70M 10-Q · filed 2026-04-29 | -$3.60M derived: sum of 2 quarters · filed 2026-04-29 | -$18.40M derived: sum of 3 quarters · filed 2026-04-29 | -$7.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$2.70M derived: sum of 2 quarters · filed 2026-02-11 | $8.00M derived: sum of 3 quarters · filed 2026-02-11 | -$1.30M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$14.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$4.10M derived: sum of 2 quarters · filed 2025-10-29 | -$13.40M 10-Q · filed 2025-10-29 | $1.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $10.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.40M 10-Q · filed 2025-08-01 | $16.30M derived: sum of 3 quarters · filed 2026-04-29 | $100.00K derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | -$9.30M 10-Q · filed 2026-04-29 | $5.60M derived: sum of 2 quarters · filed 2026-04-29 | -$10.60M derived: sum of 3 quarters · filed 2026-04-29 | -$1.40M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $14.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$1.30M derived: sum of 2 quarters · filed 2026-02-11 | $7.90M derived: sum of 3 quarters · filed 2026-02-11 | -$1.60M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$16.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$7.00M derived: sum of 2 quarters · filed 2025-10-29 | -$16.50M 10-Q · filed 2025-10-29 | -$5.90M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$300.00K 10-Q · filed 2025-08-01 | $10.30M derived: sum of 3 quarters · filed 2026-02-11 | $600.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -$9.50M 10-Q · filed 2025-04-25 | $1.10M derived: sum of 2 quarters · filed 2026-02-11 | -$8.60M derived: sum of 3 quarters · filed 2026-02-11 | $1.30M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $900.00K derived: sum of 2 quarters · filed 2026-02-11 | $10.80M derived: sum of 3 quarters · filed 2026-02-11 | $300.00K 10-K · filed 2026-02-11 |
| 2023-09-30 | -$9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $200.00K derived: sum of 2 quarters · filed 2024-10-25 | -$10.30M 10-Q · filed 2024-10-25 | $1.00M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $9.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | -$600.00K 10-Q · filed 2024-07-26 | $10.70M derived: sum of 3 quarters · filed 2025-02-07 | $400.00K derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | -$10.50M 10-Q · filed 2024-04-26 | $800.00K derived: sum of 2 quarters · filed 2025-02-07 | -$9.50M derived: sum of 3 quarters · filed 2025-02-07 | -$400.00K derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $1.00M derived: sum of 2 quarters · filed 2025-02-07 | $10.10M derived: sum of 3 quarters · filed 2025-02-07 | $100.00K 10-K · filed 2025-02-07 |
| 2022-09-30 | -$10.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$1.20M derived: sum of 2 quarters · filed 2023-10-27 | -$11.20M 10-Q · filed 2023-10-27 | $11.60M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$900.00K 10-Q · filed 2023-07-28 | $21.90M derived: sum of 3 quarters · filed 2024-02-14 | $4.20M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$10.00M 10-Q · filed 2023-04-28 | $12.80M derived: sum of 2 quarters · filed 2024-02-14 | -$4.90M derived: sum of 3 quarters · filed 2024-02-14 | $13.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $22.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $5.10M derived: sum of 2 quarters · filed 2024-02-14 | $23.00M derived: sum of 3 quarters · filed 2024-02-14 | $5.30M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$17.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $200.00K derived: sum of 2 quarters · filed 2022-10-28 | -$17.50M 10-Q · filed 2022-10-28 | -$36.50M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $17.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $200.00K 10-Q · filed 2022-07-29 | -$18.80M derived: sum of 3 quarters · filed 2023-02-14 | -$29.50M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$17.70M 10-Q · filed 2022-04-29 | -$36.70M derived: sum of 2 quarters · filed 2023-02-14 | -$47.40M derived: sum of 3 quarters · filed 2023-02-14 | -$108.20M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$29.70M derived: sum of 2 quarters · filed 2023-02-14 | -$90.50M derived: sum of 3 quarters · filed 2023-02-14 | -$29.70M 10-K · filed 2023-02-14 |
| 2020-09-30 | -$10.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$71.50M derived: sum of 2 quarters · filed 2021-10-29 | -$10.70M 10-Q · filed 2021-10-29 | -$71.60M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | -$60.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $0.00 10-Q · filed 2021-07-30 | -$60.90M derived: sum of 3 quarters · filed 2022-02-11 | -$600.00K derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $60.80M 10-Q · filed 2021-04-28 | -$100.00K derived: sum of 2 quarters · filed 2022-02-11 | $60.20M derived: sum of 3 quarters · filed 2022-02-11 | -$1.30M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | -$60.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$600.00K derived: sum of 2 quarters · filed 2022-02-11 | -$62.10M derived: sum of 3 quarters · filed 2022-02-11 | -$2.40M 10-K · filed 2022-02-11 |
| 2019-09-30 | $60.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | -$1.20M derived: sum of 2 quarters · filed 2020-10-27 | $58.50M 10-Q · filed 2020-10-27 | |
| 2019-06-30 | -$61.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$1.80M 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $59.70M 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | -$2.40M 10-K · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |